LIMS IQ Named Cloud LIS Software Solutions Company of the Year 2026

LIMS IQ has been recognized by Life Sciences Review as Cloud LIS Software Solutions Company of the Year 2026. The publication’s profile highlights how the platform supports modern laboratories that need a cloud-native system for orders, specimens, results, patient access, clinician access, integrations, analytics, and operational oversight.

For LIMS IQ, the recognition reflects a practical shift happening across clinical and specialty laboratories. Testing volume is rising, workflows are becoming more connected, and teams need fewer disconnected systems between accessioning, instruments, EMRs, billing, reporting, and patient communication. A cloud LIS has to do more than store results. It has to coordinate the laboratory’s daily work while keeping information secure, visible, and available to the people who need it.

What Life Sciences Review Highlighted

The Life Sciences Review profile focuses on several parts of the LIMS IQ platform:

• Cloud-native deployment that helps laboratories scale users, locations, and testing volume without maintaining legacy server infrastructure.
• Configurable workflows for clinical diagnostics, toxicology, molecular diagnostics, cytology, chemistry, and next-generation sequencing.
• Unified access for laboratory teams, clinicians, and patients through connected portals.
• Integration support for instruments, EMRs, billing systems, and other laboratory systems.
• Role-based access controls, encrypted data transmission, secure authentication, and support for HIPAA, CAP, and CLIA-aligned operations.
• Operational dashboards that give teams visibility into sample volume, turnaround time, utilization, revenue indicators, and workload.

Those capabilities match the core direction of LIMS IQ: a laboratory platform that adapts to how each lab works rather than forcing the lab to reorganize around rigid software.

Why This Matters for Modern Labs

Many laboratories still manage critical work across separate systems, spreadsheets, manual handoffs, and vendor-specific interfaces. That fragmentation creates delays and makes it harder to see what is happening across the operation. It can also add risk when results, status updates, billing data, and patient communication are spread across disconnected tools.

LIMS IQ is built to centralize those workflows in one cloud environment. Lab teams can configure the system around their accessioning model, test catalog, reporting rules, instrument connections, EMR workflows, review steps, and user roles. Directors and managers can track operational data in real time instead of waiting for manual reports. Clinicians and patients can access information through connected portals rather than separate communication paths.

The result is a more coordinated operating model for laboratories that need speed, accuracy, compliance, and room to grow.

Continuing the Platform Roadmap

The Life Sciences Review profile also notes that LIMS IQ is continuing to invest in platform enhancements, including a second-generation release planned for later in 2026. The roadmap includes expanded automation tools, a refreshed interface for daily laboratory tasks, enhanced AI support for laboratory teams, and additional customization options for specialized workflows.

That work continues the same product direction behind this recognition: helping laboratories bring more clarity, control, and automation to complex operations while supporting the clinicians and patients who depend on accurate results.

Read the full Life Sciences Review profile: LIMS IQ | Cloud LIS Software Solutions Company of the Year - 2026.